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Abstract The acceptability of nanomedical appli-
cations, which have the potential to generate ethical
and societal impacts, is a significant factor in the
deployment of nanomedicine. A lack of fit between
nanomedical applications and society’s values may
result from a partial consideration of such impacts.
New approaches for technological evaluation focused
on impact perception, acceptance, and acceptability
are needed to go beyond traditional technology
assessment approaches used with nanotechnology,
which focus mainly on toxicological and safety
criteria. Using a new evaluative approach based on
perceived impacts of nanotechnology, the objective
of this study was to assess perceptions among
researchers and research trainees familiar with emer-
gent technologies and from different disciplinary
background the scope of acceptability judgments
made towards the use of nanocarriers. This mixed-
methods study was based on scenarios presenting two
types of drug-delivery nanocarriers (carbon, synthetic
DNA) in two contexts of use (lung cancer treatment,
seasonal flu treatment). Researchers and research
trainees in the natural sciences and engineering, and
the social sciences and the humanities were invited by
email to take part in this project. An online
questionnaire followed by semi-directed interviews
allowed characterization of disciplinary divergences
regarding to impact perception, acceptance, and
acceptability of the scenarios. The results suggest
that impact perception is influenced by disciplinary
culture. Also, trends can be seen between respon-
dents’ profiles and variables of acceptance and
acceptability, and certain components of the accept-
ability judgement are specific to each disciplinary
culture. The acknowledgment and consideration of
these disciplinary divergences could allow, among
others, for opening up interdisciplinary dialogue on
matters related to the acceptability of nanomedical
applications and their developments.
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Introduction
Advances in nanotechnologies (NT) offer promising
avenues of applications across many fields but also
raise important ethical, legal and social implications
(ELSI) for these applications (Grieger et al. 2010;
Roco and Bainbridge 2005). It is now more and
recognized that omitting to take these issues into
account can compromise the downstream deployment
of NT (Fisher et al. 2006). Questions related to the
acceptability of new applications of NT must be
addressed upstream and midstream through con-
tinuous technology evaluations with the different
stakeholders involved in the development, deploy-
ment and use of NT (CEST 2006). Traditional
approaches of technology evaluation are centered on
the concept of acceptance and tend to focus on the
examination of factors linked to the prediction of the
intention to use or the willingness to pay from targeted
users of a technology (Siegrist et al. 2007a; Slovic
1987). Risk perception, where risk refers to the danger
of death or injury, is often emphasized in such
evaluations, whereas other factors valued by the
public are seldom considered (Kahan et al. 2009;
Sandler and Kay 2006). The tumultuous history of the
worldwide production and consumption of genetically
modified organisms (GMOs) is a good example of this
phenomenon. Indeed, even though regulatory bodies
in North America and Europe deemed the consump-
tion of GMOs as safe, social tensions emerged when
the public rejected this new technology, judging that
its risks outweighed the predicted benefits (Gaskell
et al. 2004; Roco et al. 2008). In this case, the members
of the public perceived possible impacts of the
production and consumption of GMOs on a complex
set of ethical, environmental, economic, legal and
social aspects, and gave these issues weight in their
judgements of acceptability (Patenaude et al. 2015).
An assessment approach going beyond a judgement
about facts—acceptance—and tending instead to-
wards a judgement about values—acceptability—
could have enhanced the understanding of all stake-
holders’ values, allowing developers of GMOs to
emerge from this stalemate and better direct their
development in accord with societal values. How does
this apply to NT? As the bulk of research on nano
materials is focused on public acceptance based on
toxicological and safety criteria (Nabeshi et al. 2011;
Wang et al. 2011), the same can happen. While
judgement from the public will be modulated by these
criteria and with the specific application of NT
considered, undeniably ELSI will come into play in
the judgements of acceptability. Assessment ap-
proaches incorporating those implications could help
in preventing a failure between new technologies and
society’s values (Bennett and Sarewitz 2006; Mnyusi-
walla et al. 2003).
Historically, through scientific communication, re-
searchers have contributed to shaping public perception
and opinion on NT (Corley et al. 2011; Ho et al. 2010).
In a context of participative governance, researchers’
perspective may also be used as a reference to open up
discussion on the development of NT (Sahoo 2013). As
researchers from numerous fields are involved in the
development of NT, their perspectives regarding NT
are wide-ranging and traditionally communicated
through reports and publications in isolation according
to the disciplinary culture. Given the range of the
possible ELSI of NT applications, new approaches will
have to bridge the gap between researchers’ discourse
in natural sciences and engineering (NSE) and social
sciences and humanities (SSH). Moreover, the judge-
ment of experts in NSE serves no longer as a warrant of
reliability for new technologies, the way it did a few
decades ago. Thus, the assessment of researchers in the
SSH, whose point of view brings a different perspec-
tive, must therefore be taken into account when a new
technology is being developed (Denicourt 2006;
Scheufele and Lewenstein 2005). With uncertainties
attached to NT and present-day democratic societies no
longer satisfied with the technological criteria of
efficacy, efficiency, and safety as grounds for the
acceptability of a technology, experts in the NSE will
also be called upon to integrate this reflective approach
into the process of developing new technologies in
order to develop their perspective. In a context of
midstream modulation, combined perspectives of re-
searchers from both sets of disciplinary cultures might
be beneficial to NT development by enhancing the
richness of the debate. However, previous works on the
perceptions of risks and benefits and on the acceptance
of NTs have shown that researchers in the NSE
involved in the development of new technologies
perceive, and feel concerned by ELSI (Besley et al.
2008; Gupta et al. 2013; Siegrist et al. 2007b), even
though they sometime ‘‘are unable to make direct
connections between ethics and what they do’’ [(Berne
2006) quoted in (Bassett 2012)]. The importance of the
186 Page 2 of 17 J Nanopart Res (2015) 17:186
123
complementary viewpoints of experts from both sets of
disciplinary fields calls for recourse to interdisciplinary
dialogue when addressing questions of NT accept-
ability. Identifying divergences between disciplinary
cultures (DC) of SHE and NSE toward NT could allow
for a better planning of the space for such an
interdisciplinary dialogue and a reciprocal understand-
ing of the perspectives of all the players.
The influence of scientists’ DC on the perception of
risks associated with NTs has been studied by
numerous authors. Some studies have revealed major
variations attributable to the frames of reference
embedded in the different disciplinary backgrounds
(Powell 2007) and to the epistemological frameworks
specific to each discipline (Althaus 2005; Lafontaine
2003). Working with varied disciplinary profiles,
(Weisenfeld and Ott 2011) confirmed that DC exerts
an influence on the perception of technological risk.
The study took four areas of application into account
(renewable energies, genetic engineering, nanotech-
nology, and information and communication tech-
nologies) and showed that the type of application
studied influenced risk perception, a finding confirmed
regarding NT applications for water and food by
others (te Kulve et al. 2013). Patra et al. (2010)
confirmed that the majority of NT practitioners
questioned perceive ethical impacts to be related to
the development of their technologies. However, no
specific disciplinary difference emerged among these
scientists, all of whom had backgrounds in NSE. An
overview of the literature reveals that few studies have
emphasized the heterogeneous nature of the status of
expert in NT and that a gap remains when it comes to
studying impact perception and acceptability of nan-
otechnological applications among players in the SSH.
Medicine is a field of application where advances in
NT are likely to knock down many technological
barriers, creating opportunities for new diagnostics
tools and clinical interventions (Nijhara and Balakr-
ishnan 2006). The areas of application for nanomedi-
cine (NM), defined as medicine on the molecular scale
(Freitas 2005), or as the application of NT to health
care (Farokhzad and Langer 2006), are vast and range
from prevention to diagnosis and treatment. NM is
likely to give rise to numerous impacts on society as
well as on the representations of the human being and
health (Allhoff 2009). Conflicts around redistribution,
justice, and equity in health care must also be
considered anew in the context of NM (Allhoff
2009; Bawa and Johnson 2009). Even though it has
been documented that practitioners in the field of
health care perceive some ethical issues associated
with the application of NTs in medicine but without
recognizing them as new issues specific to NM (Silva
Costa et al. 2011), experts’ impact perception in direct
connection with NM has not been studied. Among all
the nanomedical applications, targeted drug delivery
by nanocarriers is amongst the forerunner in terms of
promises and R&D efforts in NM. Advances in this
sphere could broaden the range of therapeutic agents
used and help in developing new approaches to direct
active principles directly to the desired targets for
therapy (Bawa and Johnson 2009; Hughes 2005). This
could be particularly impactful in cancer therapy (Peer
et al. 2007; Ranganathan et al. 2012).
Several studies have examined perceptions and
acceptance of NT applications in general, but the topic
of NM per se has barely been touched upon, with any
deepened exploration of these concepts in relation to
tangible applications. Based on a new conceptual
framework (Patenaude et al. 2015), a first portion of
this study has described the variables of impact
perception, acceptance, and acceptability in relation
to two materials (carbon nanocarrier, synthetic DNA
nanocarrier) and two contexts of use (lung cancer
treatment, seasonal flu treatment) in researchers
(Chenel et al. 2015). It was shown that although the
material from which the nanocarrier is made influ-
ences perceived impacts, it does not influence accep-
tance and acceptability. Context of use, on the other
hand, strongly influences the responses of acceptance
and acceptability towards the nanocarriers. The pre-
sent work is a continuation of the same project and
completes the portrait of the variables of impact
perception, acceptance, and acceptability, while al-
lowing a better understanding of the potential diver-
gences related to DC. The primary objective of this
study is to analyse the effect of DC of researchers and
research trainees on their perception of impacts, their
acceptance, and their acceptability in relation to two
kinds of targeted drug-delivery nanocarrier in two
contexts of use. The secondary objectives are to
examine the relationships between these variables, in
relation to respondents’ DC, and to explore accept-
ability judgements in relation to possible cultural
divergences.
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Materials and methods
Conceptual framework and study design
The study relies on a new theoretical framework for
the analysis of the impacts and acceptability of NT
proposed by Patenaude et al. (2015). This framework
takes into account the considerations related to all of
the ethical, environmental, economic, legal and social
aspects. In addition to the nature of the considerations,
this framework also allows for the targeting not only of
the risks (negative impacts) but also of the benefits
(positive impacts) that could flow from the develop-
ment and use of new technologies. The first part of the
framework relates to the perceived impacts of the
technology being assessed. Impact perception is
defined as a two-dimensional examination of per-
ceived impacts, based on the estimated probability of
occurrence of given impacts (identification) and on the
importance assigned by a participant to each of these
impacts (evaluation). A second variable integral to the
framework refers to acceptance. Individual acceptance
is defined as the intention by a user to use a technology
or a device in a specified context of use, while social
acceptance corresponds to a personal evaluation of the
level of development desirable for society of a
technology or a device with a specified use. Last, the
deployment of the third variable integral to the
framework, acceptability, allows for going beyond
the simple fact of acceptance and consists of a
weighting of the technology’s or device’s impacts on
certain priority issues, in order to arrive at a value
judgement about what is acceptable. Individual ac-
ceptability refers to the value judgment regarding all
the impacts that accounts for individual acceptance,
while social acceptability refers to the value judgment
regarding all the impacts that accounts for the
evaluation of the desirable level of development.
Using this conceptual framework, a two phase mixed-
methods design (quantitative phase with web-based
questionnaire, qualitative phase with semi-directed
interviews) with a sequential data triangulation
(QUANTITATIVE ? qualitative) was chosen to de-
velop multiple perspectives and a complete under-
standing of the research objectives proposed. An
Institutional Review Board of the Centre Hospitalier
Universitaire de Sherbrooke (CHUS) approved the
two phases of the study and participants gave their
consent to participate.
Study participants and recruitment
Web-based questionnaire
The recruitment strategy for the study participants in
the quantitative phase was based on the identification
through a exhaustive literature review and on-line
search using keywords such as nanotechnology,
nanomedicine, ethics, social sciences, and new tech-
nologies of authors publishing on topics associated
with new technologies and or individuals having
affiliations with research groups, labs, or networks that
conduct research on the new technologies (for exam-
ple, the NE3LS Network on Nanotechnology
(NE3LS NetWork 2014)—Canada and Pacte—Social
Science Research Laboratory (PACTE 2014)—
France). As the questionnaire was developed and
tested in French, for reasons related to language, only
Francophone researchers and research trainees were
targeted. To obtain the largest possible number of
respondents, recruitment was conducted among re-
searchers and research trainees in Canada and Europe.
A list of 1527 researchers and research trainees
(graduate students) was generated as potential par-
ticipants—the term researcher will be used generical-
ly from this point to describe all participants. An email
inviting the recipient to fill out the web-based
questionnaire was sent to the targeted researchers
(n = 1320 valid invitations, 230 invalid emails) in
September 2013, followed by two reminder emails.
Semi-directed interviews
At the end of the web-based questionnaire, re-
searchers who were interested in taking part in the
qualitative phase were invited to provide their contact
information—stored separately from the other data by
email. From December 2013 to April 2014, the semi-
directed interviews were conducted with a final
subsample of about 10 % of the researchers who
had completed the quantitative phase (n = 22). Par-
ticipants in the qualitative phase were chosen based on
their DC and their geographical location to ensure a
representative sample of participants recruited in the
quantitative phase. Interviews lasted on average one
hour and were conducted in person (n = 15), or by
means of a teleconferencing or videoconferencing
system (n = 7).




The study’s quantitative phasewas in the formof aweb-
based questionnaire based on the operationalization of
the conceptual framework designed by Patenaude et al.
(2015). The variables of impact perception, acceptance,
and acceptability were considered through the optics of
a scenario-based approach. Scenarios related to the use
of two kinds of drug-delivery nanocarrier (carbon
nanocarrier, syntheticDNAnanocarrier) in twocontexts
of use (lung cancer treatment, seasonal flu treatment)
were presented to the participants. Six major positive
and negative impacts (drawn from a review of the
literature) on issues of health, the environment, and
social cohabitation associated with NM were then
presented to participants. Impact perception was mea-
sured by combining the respondent’s estimation of the
probability that a given impact would arise and the
importance assigned by the respondent to each such
impact. This yielded a perception index (PI) that might
be negative, neutral, or positive. Individual acceptance
(IndAtce) was measured based on the respondent’s
intention to use each type of treatment in each of the two
clinical contexts. Social acceptance (SocAtce) was
based on the level of development for the treatment
that the respondent deemed desirable for society.
Acceptabilitywasmeasured by establishing aweighting
of the positive and negative impacts perceived and
prioritized by the respondent in arriving at the decision
regarding personal use or in arriving at the level of
development deemed desirable for society. This yielded
an individual acceptability index (IndAI) and a social
acceptability index (SocAI) that bothmight be negative,
neutral, or positive. The questionnaire included two
subvariables of acceptability, namely preponderant
issue (IndPIssue, SocPIssue) and perceived usefulness
(Useful/Ind, Useful/Soc). The preponderant issue offers
a portrait of the issue or issues prioritized in arriving at
the individual and social judgements of acceptability.
This variable also highlights whether a single issue
(health, the environment, social cohabitation) was
prioritized by respondents or whether in contrast it
was a combination of issues that characterized respon-
dents’ judgements of individual (IndPIssue) and social
(SocPIssue) acceptability. Perceived usefulness mea-
sures the extent towhich a respondent deemed eachkind
of nanocarrier in each clinical context to be useful to
himself/herself and to society. This variable does not
constitute an integral part of the conceptual framework,
but is a constituent variable in traditional Technology
Assessment Models (TAM) (Davis 1989). All variables
were measured with four-point Likert scales (for more
detail, see Chenel et al. 2015).
Before being posted online, the questionnaire was
pretested by means of cognitive interviewing (Willis
2004). Participants (n = 35) who were representative
of the population under study were recruited and asked
to complete the questionnaire in person while we
observed them and an interviewer debriefed them after
each question. Three cycles of interviews to optimize
the questionnaire components (instructions, key con-
cepts, scenario presentation, questions and response
options) and test the robustness and usability (com-
pletion time, ease of administration, visual aspect) of
the on-line version were conducted and changes to the
questionnaire were made after each cycle. In the last
round, an average completion time was calculated to
serve as a quality control measure for the question-
naires completed during the study.
Qualitative phase
The same scenarios presented in the questionnaire for the
use of the drug-delivery nanocarriers were also presented
to participants in the qualitative phase. An interview
guide was developed using preliminary analysis of the
quantitative data collected in the quantitative phase to
explore specific theme in the semi-directed interviews.
The interview guide was focused on the components of
the acceptability judgment as presented in the question-
naire but in amore open and flexible manner andwithout
imposing limits on the choice of answers. Probes from
the interviewer were added to allow the exploration of
the various facets of acceptability by placing in relation
to each other the two contexts of use, the two kinds of
nanocarrier, notions of usefulness and effectiveness, and
the reasons why a respondent’s judgement might be
modulated in a given situation.
Data analysis
Statistical analysis of quantitative data
The influence of DC on the variables of impact
perception, acceptance, and acceptability, in relation
to the different kinds of nanocarrier and the two
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contexts of use, were tested using the Mann–Whitney
U test and the Pearson Chi square test for indepen-
dence. A multiple correspondence analysis (MCA)
was performed in order to examine relationships
between core variables and respondents’ profiles. This
analysis, which is specific to categorical variables (and
part of a family of descriptive methods that includes
clustering and factor analysis and principal compo-
nents analysis), reveals patterning in complex datasets
and enables the visualization of independent clusters
on (usually) a two-dimensional plane (Greenacre
2007). All statistical tests used an alpha of 0.05.
Analyses were performed using SPSS Statistics v20.
(IBM Corporation, Armonk, NY).
Thematic content analysis of qualitative data
Individual interviews were audio-recorded and then
transcribed verbatim with no reformulation by a third
party. The verbatim were read while playing back the
audio recordings to ensure adequacy of transcriptions
and familiarise with the themes handled in each
interview. A thematic content analysis approach was
used to objectively and systematically capture the
discourse of the researchers interviewed (Berelson
1971). A mixed coding method based on the
theoretical framework guided the identification, re-
viewing, and classification of the interview’s compo-
nents (Paille´ and Mucchielli 2012). Coding was
conceptualized based on general themes from the
major categories of existing issues described in the
framework, but was also open to the emergence of
code related to the theme of acceptability. Analysis
was based on the occurrence of themes in each
researcher’s discourse, rather than on the frequency of
themes’ occurrence. This allowed for examining the
recurrence of these themes within each DC and for
highlighting divergences in the remarks made by the
groups under study (Mucchielli 1979). Analyses were
performed by VC using the qualitative data analysis
software, Dedoose v4.12 (SocioCultural Research
Consultants, UCLA, CA).
Results
For the quantitative phase, 1320 researchers were
contacted, 585 accessed the questionnaire (44.32 %
access rate), and 214 completed it satisfactorily
(16.21 % response rate meeting quality criteria). Of
all respondents (n = 214), 71 % identified themselves
as researchers and 29 % as research trainees. Sixty-
seven percent of respondents were in the fields of the
NSE and the rest in the fields of the SSH. Europeans
accounted for 66 % of respondents (France = 58 %;
Belgium = 5 %; Switzerland = 2 %; Italy = 1 %).
Men accounted for 63 % of the sample. For the study’s
qualitative phase, the final subsample (n = 22) in-
cluded European researchers (n = 11) in NSE (n = 6)
and SSH (n = 5) and Canadian researchers (n = 11)
in NSE (n = 5) and SSH (n = 6) from diverse
disciplinary background (see Table 1).
Comparisons between nanocarriers and contexts
of use in relation to disciplinary culture
A comparison of perception indexes (PI) reveals the
influence of DC on impact perception for the two kinds
of nanocarriers. The results show that NSE researchers
have a greater perception of positive impacts than do
SSH researchers (p\ 0.01Mann–WhitneyU test), for
both the carbon nanocarrier (31.47 vs. 18.31 %) and
the synthetic DNA one (44.76 vs. 25.35 %). SSH
researchers have a greater perception of negative
impacts than do NSE researchers (p\ 0.01 Mann–
Whitney U test), for both the carbon nanocarrier
(46.48 vs. 27.27 %) and the synthetic DNA one (40.85
vs. 23.08 %) (see Table 2).
With regards to acceptance, no significant disci-
plinary difference (p[ 0.05 Pearson Chi square
independence test) was observed in the scores for the
variables of IndAtce and SocAtce for the two kinds of
nanocarrier. This was the case for both contexts of use.
Researchers from both sets of disciplinary back-
grounds accepted personal use of the carbon nanocar-
rier (rates of acceptance: NSE = 93.01 %, SSH =
94.37 %) as well as the synthetic DNA one (rates of
acceptance: NSE = 93.01 %, SSH = 85.92 %) to
treat lung cancer. On the other hand, for the treatment
of seasonal flu, respondents were hesitant about
personal use of both the carbon nanocarrier (rejection
rates: NSE = 79.02 %, SSH = 84.51 %) and the syn-
thetic DNA one (rejection rates: NSE = 79.72 %,
SSH = 81.69 %). Similar results were obtained re-
garding social acceptance.
As for the acceptability index (AI) in the context of
lung cancer treatment, a comparison between DCs
reveals significant differences (p\ 0.01 Mann–
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Whitney U test). Researchers from NSE fields ap-
peared to have based on their judgements of accept-
ability on positive impacts to a greater extent than did
SSH researchers. For individual acceptability, this was
the case for the synthetic DNA nanocarrier to treat lung
cancer (NSE = 81.82 %, SSH = 64.79 %). The find-
ings about the social acceptability for the lung cancer
treatment were similar for the carbon nanocarrier
(NSE = 78.32 %, SSH = 59.15 %) as well as for
the synthetic DNA one (NSE = 81.12 %, SSH =
56.34 %). No cultural difference was observed for
acceptability in using a seasonal flu treatment.
An examination of PIssue relating to the carbon
nanocarrier reveals certain cultural differences
(p\0.05 Chi square independence test) when it comes
to the issues prioritized in the acceptability judgement
(see Fig. 1). Cultural differences were noted as regards
the IndPIssue for the seasonal flu treatment aswell as the
SocPIssue for the lung cancer treatment. NSE re-
searchers appear to have based on their acceptability
judgements against the personal use of seasonal flu
treatment on health issues (NSE = 52.4 %, SSH =
32.4 %), while SSH researchers also significantly
emphasized environmental issues in accounting for
their rejection (NSE = 5.6 %, SSH = 18.3 %). Con-
cerning the social acceptability of the lung cancer
treatment, NSE researchers based their favourable
judgement on health issues (NSE = 63.6 %,
SSH = 46.5 %), while SSH researchers assigned im-
portance to environmental and social cohabitation issues
as well. On the other hand, for lung cancer treatment, no
cultural differences relating to IndPIssuewere observed,
with health being prioritized by researchers from both
sets of disciplinary backgrounds (NSE = 86.7 %,
SSH = 73.2 %); nor were cultural differences observed
at the social level for the treatment of seasonal flu, with
all issues (health, the environment, social cohabitation)
being emphasized in a more evenly distributed manner.
Relationships between impact perception,
acceptance, and acceptability in relation
to researchers’ profiles
An examination of the relationships among variables
and respondents’ profiles was carried out by including
Table 1 Brief profile of
researchers and research
trainees
NSE Natural sciences and
engineering, SSH social
sciences and humanities, SI.
No. subject identification
number
SI. No. Disciplinary culture Disciplinary background Social culture
QSNF03 NSE Biology—nanomedicine France
QSNF02 NSE Chemistry—nanomaterials France
QSNF01 NSE Chemistry—nanosensors France
QSNQ03 NSE Chemistry engineering—nanotechnology Canada
QSNQ01 NSE Electric engineering—nanotechnology Canada
QSNQ05 NSE Electric engineering—nanotechnology Canada
QSNF05 NSE Informatics—biotechnology France
QSNF04 NSE Medicine—radiation oncology France
QSNQ02 NSE Microbiology—nanosensors Canada
QSNF06 NSE Nanomedicine—biomimicry France
QSNQ04 NSE Process chemistry Canada
QSHSQ04 SSH Applied ethics—neuroethics Canada
QSHSQ02 SSH Bioethics—clinical research Canada
QSHSQ01 SSH Bioethics—epigenetics Canada
QSHSQ05 SSH Ethics—anthropology Canada
QSHSQ06 SSH Ethics—technological innovation Canada
QSHSF03 SSH Human factors and ergonomics France
QSHSF02 SSH Philosophy—applied Ethics France
QSHSF05 SSH Philosophy—applied Ethics France
QSHSQ03 SSH Philosophy—applied Ethics Canada
QSHSF04 SSH Physics—ethics of nanotechnology France
QSHSF01 SSH Sociology of sciences France
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in the model disciplinary culture (NSE, SSH), social
culture (European, Canadian), sex, and occupation
(researcher, research trainee) in addition to PI,
IndAtce, SocAtce, IndAI, SocAI, Useful/Ind and
Useful/Soc. The analysis was performed for the
scenario that had elicited the greatest variation in
responses, namely the carbon nanocarrier to treat
seasonal flu.
Performing a MCA on all the data (n = 214)
relative to the chosen scenario reveals a total ex-
plained inertia of 63.3 %, of which 36.9 % is
attributable to dimension 1, corresponding to the
orientation (positive/negative) of modalities, and
26.2 % is attributable to dimension 2, corresponding
to the polarization (low/high) of modalities. Cron-

















Carbon Significance Synthetic DNA Significance
NSE (%) SSH (%) NSE (%) SSH (%)
PI comparisons across nanocarrier compositions
PI
Positive 31.47 18.31 p\ 0.01 44.76 25.35 p\ 0.01
Neutral 41.26 35.21 32.17 33.80
Negative 27.27 46.48 23.08 40.85
Acceptance and acceptability of a drug-delivered treatment for lung cancer
IndAtce
Accept 93.01 94.37 p = 0.705 93.01 85.92 p = 0.093
Not accept 6.99 5.63 6.99 14.08
IndAI
Positive 80.42 67.71 p = 0.060 81.82 64.79 p\ 0.01
Neutral 11.19 23.94 9.09 19.72
Negative 8.39 8.45 9.09 15.49
SocAtce
Accept 92.31 92.96 p = 0.865 92.31 85.92 p = 0.139
Not accept 7.69 7.04 7.69 14.08
SocAI
Positive 78.32 59.15 p\ 0.01 81.12 56.34 p\ 0.01
Neutral 12.59 32.39 11.19 29.58
Negative 9.09 8.45 7.69 14.08
Acceptance and acceptability of a drug-delivered treatment for seasonal flu
IndAtce
Accept 20.98 15.49 p = 0.337 20.28 18.31 p = 0.733
Not accept 79.02 84.51 79.72 81.69
IndAI
Positive 25.17 21.13 p = 0.945 25.87 19.72 p = 0.364
Neutral 19.58 25.35 23.08 23.94
Negative 55.24 53.52 51.05 56.34
SocAtce
Accept 23.78 14.08 p = 0.099 22.38 16.90 p = 0.351
Not accept 76.22 85.82 77.62 83.10
SocAI
Positive 29.37 19.72 p = 0.878 30.77 25.35 p = 0.639
Neutral 21.68 36.62 23.78 28.17
Negative 48.95 43.66 45.45 46.48
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consistency for all measured items. Only IndAtce
(D1 = 71.4 %; D2 = 67.9 %), UsefulInd (D1 =
65.8 %; D2 = 68.1 %), SocAtce (D1 = 75.9 %; D2 =
58 %), and UsefulSoc (D1 = 72.7 %; D2 = 80.6 %)
presented strong correlations with dimension 1 and
dimension 2. All other variables were weakly correlated
with both dimensions. A visualization of the MCA
results is presented in Fig. 2. The graph coordinate
reveals seven clusters. Clusters 1 and 2 bring together
respondent profiles that share certain characteristics in
relation to the variables under study. Thus cluster 1
groups together researchers, individuals fromSSHfields,
women, and Europeans; while cluster 2 groups together
research trainees, individuals from NSE fields, Canadi-
ans, and men. Clusters 3, 5, 6, and 7 illustrate the
proximity of the modalities for the variables IndAtce,
SocAtce,UsefulInd, andUsefulSoc, testifying to a strong
relationship among these variables. Clusters 4 and 7
illustrate the proximity between the modalities for the
variables PI, IndAI, and SocAI, attesting in this instance
to a less strong relationship among these variables.
The results of this analysis do not allow for
pinpointing clear relationships between respondents’
profiles and the variables under study. Two meta-
clusters, however, do allow for drawing a link
between each profile and a general trend. Metaclus-
ter A incorporates the profile of respondents asso-
ciated with cluster 1 (researchers, SSH, women,
Europeans) and assimilates it to those diagram
modalities that are negatively oriented to dimension
1. Cluster 1 thus presents a profile of respondents
that are more likely to resist using the carbon
nanocarrier to treat the flu, based on an emphasis on
the negative impacts. On the other hand, metacluster
B incorporates the profile of respondents associated
with cluster 2 (research trainees, NSE, men, Cana-
dians) and assimilates it to those diagram modalities
that are positively oriented to dimension 1. Cluster 2
thus presents a profile of respondents that are more
likely to favour use of the carbon nanocarrier to
treat the flu, based on an emphasis on the positive
impacts.





of use, as related to
disciplinary cultures.
Abbreviations H | E |
S = complex profile where
all issues are equally
preponderant, Env |
Soc = complex profile
where environmental and
social cohabitation issues
are preponderant, Hea |
Soc = complex profile
where health and social
cohabitation issues are
preponderant, Hea |





SSH social sciences and
humanities
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Exploration of value judgments of acceptability
Exploration of the acceptability of the two
nanocarriers in different contexts of use
The results of the quantitative phase showed that the
composition of the drug-delivery nanocarriers (carbon,
synthetic DNA) did not have a bearing on the intention
to use the treatments described, whatever the respon-
dent’s DC. The interviews made it possible to inves-
tigate this finding further and attain a deeper
understanding of the reasons for this indifference
regarding the composition of the nanocarrier. An initial
theme, focused on the importance of the medication’s
safety and on its clinical effects, may be a part of the
answer. Here is how one participant presents it:
If you bring an anti-cancer chemotherapy
molecule into the tumour zone, what counts is
the efficacy of the chemotherapy, the
chemotherapy molecule that’s brought there,
more than the capsule that brings it there. We
assume both (kinds of nanocarrier) do the same
work as carriers. | QSNF04
This theme was raised by half the participants. A
disciplinary divergence did emerge, according to
which this indifference regarding the composition of
the nanocarrier was prevalent among NSE researchers
and less present among SSH researchers. Another
aspect of this indifference to the composition of the
nanocarrier in the context of use has to do with the
interviewees’ self-perception as experts. In a context
of sickness, they find themselves playing the role of
patient, with no real ability to form a judgement that
matches the competency of the attending physician.
Here is a quotation that illustrates this reality:
When you go to the hospital as a patient, from


















o = Neutral, ? = Positive
for PI, IndAI, and SocAI;
- - = Wholly disagree,
- = Somewhat
disagree, ? = Somewhat






Eu. Europe, Can. Canada;
M male, F female; Stu.
research trainee (graduate
student), Res. researcher
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patient gown, you go from the status of normal
individual to the status of patient. So you enter
into a relationship that I’d call, in quotation
marks, one of ‘‘inferiority’’ to the physicians,
nurses, the medical staff, who have the knowl-
edge and experience. So since you don’t have the
medical competence, you’re obliged to trust in
their competence. And since, besides, to a
greater or lesser extent they have your life in
their hands, well, you trust them. | QSNF03
It would thus appear that a second theme, focused
on the physician’s expertise and on confidence in the
medical staff, could account for the fact that, for some
respondents in both sets of disciplines, it seems
unreasonable to express a personal preference regard-
ing a detail as precise as the composition of the
nanocarrier—which is not itself the active agent—for
a medical treatment.
In contrast, the clinical context seems to be a source
of great variation in terms of acceptability among the
researchers. While the composition appears to have
had no impact on acceptance or acceptability regard-
ing the treatments presented in the scenarios, the
interviews did reveal that the context of use played a
part in the intention to use a treatment. In entering
more deeply into this question, some key elements
allowed for an understanding of these distinctions in
relation to acceptance and acceptability for lung
cancer treatment and flu treatment. An examination
of acceptability judgements revealed different view-
points on the acceptability of nanocarriers depending
on context of use. Even though more impacts have
been mentioned by researchers, Table 3 presents
distinctions in impacts invoked in arriving at accept-
ability judgement regarding the two context of use,
regardless to disciplinary cultures. Specifically, with
the appearance of a new kind of treatment, problems of
access and equity were highlighted in the context of lung
cancer treatment. The possibility of increased efficacy in
the treatment of this fatal disease, and increased life
expectancy, was two more factors that were more often
adduced, out of the seven that were raised as explana-
tions for the acceptability of nanocarriers in treating
lung cancer. When it came to treating the seasonal flu,
five factors were adduced. It was mentioned that a new
effective treatment for the seasonal flu could contribute
to reducing the disease’s social impact by cutting down
on transmission. On the other hand, the development of
a treatment of high complexity—using nanocarriers—
was significantly challenged:
I think that with that, you’re really using a
bazooka to kill a fly. Okay, this (i.e., nanocar-
riers), this isn’t a bazooka, but I think it’s
disproportionate, too big. | QSNF04
Other contextual factors emerged from the interviews
and allowed to document these differences related to the
contexts of use. The gravity of the disease and the
possibility of harmful consequences to health, as
compared with the benign nature and the absence of
significant consequences, are factors that can contribute
to contemplating taking a treatment or not. The
perceived seriousness of lung cancer in contrast to the
seasonal flu led the majority of respondents to accept a
treatment for the former and categorically refuse
treatment for the latter. This passage illustrates the point:
In caring for cancer, what’s at stake is patient
survival. In caring for the flu, the stakes very
rarely consist of patient survival and treatments
already exist. | QSSHF01
Nevertheless, some researchers have considered the
treatment for the seasonal flu to be sometime desirable
where a real risk to health was perceived. Although the
notion of seriousness was raised by a large number of
participants when all cultures are taken together, a
nuance related to giving consideration to populations at
greater risk in connection with less serious diseases was
raised more often by SSH researchers than NSE
researchers. Finally, the purpose of the treatment
proposed for a given use also appears to weigh in the
balance in arriving at a judgement of acceptability. A
comparison between a product aimed at contributing to
patient comfort and symptom reduction and a product
aimed at treating and curing the patient allowed for an
understanding of the variations. The perceived goal of
the treatment, as invoked in this dichotomy between
necessity and mere comfort, appears to play a role in
arriving at a judgement of acceptability for the use of a
treatment in a given context.
Exploration of judgement of a scenario’s acceptability
in relation to disciplinary culture
The in-depth examination of the acceptability towards
a single scenario, that of the carbon nanocarrier to treat
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seasonal flu, made it possible to bring into relief some
particularities of researchers’ judgement of accept-
ability as related to their DC. To flesh out the
differences observed based on quantitative data
analysis, a thematic content analysis brought out the
main issues and impacts associated with the framing of
researchers’ acceptability judgements for this sce-
nario. A list of 15 items related to issues of health, life
and death, social cohabitation, the economy, the
environment, representation of the human being and
technoscience describes all the factors invoked by the
interviewees and explaining why they accepted or not
the treatment proposed (see Table 4). A different
weighting for the positive and negative impacts was
observed as between respondents who accepted the
treatment and those who rejected it. Several factors
were common to all the researchers, but cultural
differences were observed in relation to seven of the
15 factors invoked in the acceptability judgement.
Natural sciences and engineering (NSE) re-
searchers had a more marked tendency to broach
themes related to the high cost of developing such a
specialized technology, and to the inequalities likely
to be created by use of the treatment. SSH researchers,
for their part, emphasized impacts on social cohabita-
tion. They spoke more about the social burden the
adoption of this treatment would represent, and about
the importance of being able to choose to be treated
with this method or to refuse it—attesting to the
importance of making choice possible for all members
of society, even if they personally do not agree with
the use of the treatment. They also broached gains in
productivity for patients treated. The interpretation of
this last factor may be both positive and negative.
From one perspective, the sickness of someone with an
important role could have negative impacts for
society. For example, a researcher suggested that if a
surgeon must take prolonged leave, this could lead to
negative consequences for the patients. From another
perspective, a researcher’s way of looking at his/her
own sickness allows to see how the weighting given to
the values of self-respect and productivity as a worker
can shift when the patient is at the centre of the
situation:
Sometimes I wonder if the reason we want to
solve a problem like the flu so fast, with this kind
of medication, isn’t because we’re concerned
about human health but because we’re con-
cerned about worker productivity. And that
represents a moral problem for me, because I
consider myself a human being first, a citizen
next, and a worker after that. So I want people to
take care of my humanity, then my citizenship,
and then after that let me work and not put me
back to work as fast as possible if I have a health
problem. | QSSHQ06
Social sciences and humanities (SSH) researchers
also emphasized two factors discussed earlier, namely
the possibility of increasing environmental pollution
using this kind of treatment, as noted in the analysis of
preponderant issues, and the importance of curing a
potentially fatal disease, attesting to their sensitivity
towards more vulnerable populations.
Table 3 Distinctions in
impacts invoked in arriving
at acceptability judgement
regarding context of use of
targeted drug-delivery
nanocarriers
In bold, the context of use
for which the impact has
been mainly invoked
Issue Impact Context of use
Health Resulting undesirable effects Lung cancer[Seasonal flu
Resulting desirable effects Lung cancer[Seasonal flu
Improved well-being Lung cancer[Seasonal flu
Disturbance of body’s homeostasis Lung cancer\Seasonal flu
Life and death Treatment of a potentially fatal disease Lung cancer[Seasonal flu
Improved life expectancy Lung cancer[Seasonal flu
Social cohabitation Accessibility issues/inequalities Lung cancer[Seasonal flu
Reduced impact of the disease on society Lung cancer\Seasonal flu
Increased productivity of sick people Lung cancer\Seasonal flu
Environment Increased environmental pollution Lung cancer[Seasonal flu
Economy Higher treatment costs Lung cancer\Seasonal flu
Technoscience Questioning of treatment Lung cancer\Seasonal flu
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Discussion
This study’s objectives were pursued in two phases.
First, the quantitative phase was designed to examine
the impact that researchers’ DC could have on
variables under study, namely impact perception,
acceptance, and acceptability, in relation to two kinds
of targeted drug-delivery nanocarrier in two contexts
of use; and to identify possible relationships between
respondent profiles and the variables in question. Next,
the qualitative phase was designed to shed light on
certain results of the quantitative sequence and to
explore acceptability judgements by scenario in rela-
tion to disciplinary divergences.
The results show that even while controlling for
DC, impact perception was the only variable on which
nanocarrier composition (carbon, synthetic DNA) had
an effect, in contrast to acceptance and acceptability
for which the nanocarrier composition did not appear
to be a factor of influence. Even though impact
perception is a notable covariate of acceptance and
acceptability, this points out this variable’s inadequa-
cy as a determinant of the two others and highlights the
importance of incorporating other factors and contex-
tual considerations into approaches to acceptance and
acceptability. That is, results show differences in DC
in relation to impact perception for the two kinds of
nanocarriers. SSH researchers had a greater perception
of the negative impacts of the two kinds of nanocarrier
than NSE researchers who, for their part, perceived
more positive impacts. This result is in line with what
was observed by others in the literature. Indeed, DC,
via the knowledge base acquired over the course of the
exercise of one’s responsibilities (Powell 2007) and
the epistemological grounding specific to each disci-
pline (Lafontaine 2003), has been shown to influence
the way a nanotechnological application is perceived.
However, whether a carbon nanocarrier treatment is
viewed as interchangeable with a synthetic DNA one
(or vice versa) in a given context of use appears to
depend on preconceptions about the two materials. In
interviews, the NSE researchers, perceiving to a
greater extent the positive impacts of the two kinds
of nanocarrier, were less likely to show concerns about
the interchangeability of the two kinds of nanocarrier
for a given context of use.
On the other hand, while composition may have no
effect on acceptance or acceptability, context of use
does need to be taken into account. Several studies
have shown the influence of the nature of a technology
Table 4 Identification of disciplinary differences in impacts invoked in arriving at acceptability judgement regarding use of carbon
nanocarrier to treat seasonal flu
Issue Impact Disciplinary culture
Health Resulting undesirable effects NSE = SSH
Resulting desirable effects NSE = SSH
Disturbance of body’s homeostasis NSE = SSH
Life and death Treatment of a potentially fatal disease NSE\SSH
Social cohabitation Accessibility issues/inequalities NSE[SSH
Reduced impact of the disease on society NSE = SSH
Increased productivity of sick people NSE\SSH
Higher social burden of treatment NSE\SSH
Possibility of choosing to be treated NSE\SSH
Environment Increased environmental pollution NSE\SSH
Economy Higher development costs NSE[SSH
Higher treatment costs NSE = SSH
Benefits for national market NSE = SSH
Representation of the human being Transformed definitions of health/sickness NSE = SSH
Technoscience Questioning of treatment NSE = SSH
NSE Natural sciences and engineering, SSH social sciences and humanities
Bold indicates the DC that invoked the impact more often in arriving at an acceptability judgment about treatment for the seasonal flu
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and the context on impact perception and acceptance
(Gupta et al. 2013; te Kulve et al. 2013; Weisenfeld
and Ott 2011). But so far, no one has highlighted the
influence of context of use on acceptance and accept-
ability in relation to a NM treatment. This study has
confirmed that the context of use is a factor influencing
the variables under study, even though few differences
emerged that were specific to DC. As regards accep-
tance, this may be explained by the fact that the
contexts of use were quite polarizing and thus not
highly conducive to cultural variation. The great gap
between lung cancer, perceived as catastrophic and
uncontrollable, and the seasonal flu, seen as more
ordinary and subject to control, could account for
greater acceptance in relation to the former and lesser
acceptance in relation to the latter (Slovic 1987). The
contrast between the serious nature of cancer and the
benign nature of the flu emerged during interviews as a
determining characteristic in the acceptance of a
treatment under certain conditions. Additionally, even
as confidence in government authorities would appear
to govern risk perception about NT (Siegrist et al.
2007b), the emergence of the themes of trust in the
physician and in medical expertise suggests that in the
clinical context, when it comes to acceptance, the
interviewees immediately adopt the position of user
and deploy arguments suited to this position, without
reference to their cultural profiles. However, certain
cultural differences were observed when it came to the
acceptability index and to the profile of the prepon-
derant issue as regards cancer treatment. SSH re-
searchers were more inclined to balance positive with
negative impacts, unlike NSE researchers, who were
more inclined to justify their positions by reference to
positive impacts. The greater importance assigned by
SSH researchers to the uncertainties and the unfore-
seeable long-term effects on both human health and
the environment and the lesser importance assigned to
the beneficial effects associated with the curing of
cancer, compared to NSE researchers, could account
for this cultural variation. This brings forward the
possibility that researchers in the two different disci-
plinary spheres harboured different concerns.
As for relationships, the MCA, which incorporated
both respondent profiles and the variables under study,
revealed associations among all those variables.
Notably, impact perception and acceptability yielded
similar patterns of distribution, which indicates a
degree of correspondence between these variables.
While this result fits the contexts presented, there is a
conceptual difference between perceived impacts and
those that are taken into account and prioritized during
a decision-making process (Patenaude et al. 2015).
Impacts could be perceived for certain specific use
situations (tobacco use, malnutrition), whereas an
acceptability judgement regarding these use be-
haviours could be based on different arguments. The
questionnaire’s operationalization, where the same list
of impacts was used for measuring both variables, may
have contributed to the strength of this association.
Another relationship between acceptance and per-
ceived usefulness also emerged through the MCA and
was confirmed during the interviews by respondent
remarks that weighed the necessary nature of a
treatment for a given condition. Perceived usefulness
has been documented in the literature as an important
factor in accounting for information technologies’
acceptance (Davis 1985; Venkatesh and Bala 2008).
Results suggest the transferability of this finding to
nanomedical applications. The respondent profiles
(NSE, SSH) were not associated with any of the
variables under study. However, possible comparisons
regarding the orientation of modalities of some
variables highlight certain tendencies for the profile
that includes NSE researchers to appear more opti-
mistic about the scenario presented in opposite to the
profile including SSH researchers.
An in-depth examination of researchers’ accept-
ability regarding the scenario of carbon nanocarrier
treatment for the seasonal flu enabled exploration of
the balance of perceived impacts in arriving at a
judgement of acceptability. From a quantitative
viewpoint, analysis of the acceptability index revealed
that the majority of researchers invoked negative
impacts in accounting for their acceptance. An
analysis of the preponderant issue profile, however,
yielded the conclusion that, in line with results shown
by others (Althaus 2005; Powell 2007;Weisenfeld and
Ott 2011), the factors invoked in relation to the
acceptability judgement by researchers from the two
DC differed. For instance, environmental pollution
was a significant concern for SSH researchers but was
less so for NSE researchers. The thematic content
analysis of the interview transcripts brought out other
factors underlying cultural differences. For example,
NSE researchers invoked the high cost of development
as an argument in support of a more negative
acceptability judgment towards use of carbon
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nanocarriers to treat the seasonal flu. This also applies
to the importance of making the treatment available to
all, an argument invoked by SSH researchers in favour
of the freedom of choice to those who wish to benefit
from it.
The divergences noted between researchers from
the two sets of disciplinary backgrounds underline the
importance of taking account of the depth of the
acceptability judgement and the nature of the issues
and impacts prioritized. Since acceptability judge-
ments are likely to be influenced by the profile of the
assessor, there is an inherent interest in taking the
study of acceptability to a deeper stage and under-
standing the impacts and issues acceptability judge-
ments are based on, in addition to the elements that
may modulate this judgement. The thematic analysis
of the interview contents revealed several impacts that
were identified by respondents during the interviews
but were not included in the web-based questionnaire
for practical reasons (cognitive load, completion
time). These include, for example, the high cost of
treatment to the user and concerns about the devel-
opment of treatments. The absence of some of these
impacts from the questionnaire could account for the
fact that certain differences failed to emerge in the
processing of the data from the quantitative phase but
became apparent during the interview content analy-
sis. The frequent occurrence of themes not broached
in the questionnaire but identified during the inter-
views points to the importance of taking a more
exhaustive approach in studying impact perception
and acceptability.
As regards the strengths and limitations of this
study, the credibility and reliability of the final results
were enhanced by the use of standards such as
completion time for the questionnaire results and by
the use of an interview guide in conducting the
interviews. A high degree of convergence was
observed between the quantitative and the qualitative
results, in particular with regards to acceptance and
acceptability, providing partial substantiation of the
validity of the pretested questionnaire. An understand-
ing of the disciplinary differences related to accept-
ability that emerged in the analysis of the quantitative
data was deepened through the interview process and
through triangulation offered an expanding portrait of
these cultural distinctions. However, considering the
novelty of the framework underlying the development
of the questionnaire and even though a high degree of
convergence was observed between the quantitative
and the qualitative results, the operationalization of
main concepts and the data reductions will have to be
confirmed through subsequent studies. In addition, the
sampling method and the criteria used to recruit
participants (i.e. European and Canadian Franco-
phones) limit the transferability of the findings to
other populations of researchers. Besides DC, it is
recognized that social culture, as influenced by
language, cultural heritage, political climate, eco-
nomic conditions, and ethical frames of reference, is a
factor influencing the perception of NT applications,
regarding the impacts on a set of issues (Gaskell et al.
2005; Kahan et al. 2009; Sechi et al. 2014), including
ethical issues (Schummer 2006). Social distinctions
have not been addressed here, but these differences
regarding social cultures were examined and future
works are intended to present these findings.
Conclusion
Using a mixed-methods design, this study has yielded
new empirical data on impact perception, acceptance,
and acceptability towards two kinds of drug-delivery
nanocarriers in two contexts of use, viewed through
the prism of distinctions between sets of disciplinary
backgrounds in researchers. It was found that the
context of use, the gravity of the disease, and
usefulness are important factors that must be taken
into account in assessing acceptance and acceptability
as regards to medical treatments based on NM. In
contrast, the composition of the nanocarrier, though it
affects perceived impacts, appears not to influence
acceptance or acceptability for a given context. Nor
does DC appear to modulate relationships between
these variables. During the examination of the accept-
ability of the carbon nanocarrier to treat seasonal flu,
distinct profiles emerged and trends were observed
regarding the optimism of NSG researchers and the
hesitancies of SSH researchers. The interviews also
shed interesting light on the diversity of acceptability
judgements in relation to the DC of researchers
interviewed about this scenario. Differences relating
to fields of expertise and the richness they contribute in
establishing a portrait of targeted drug delivery
reinforce the view that it is necessary to include
perspectives emerging from diverse disciplinary back-
grounds. This would encourage the intersection
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between issues traditionally associated with the NSE
on one hand and those associated with the SSH on the
other. Finally, since researchers of these sets of
disciplinary backgrounds highlight certain potential
areas of sensitivity in the development of NTs, based
not only on their academic expertise, but also as regard
their status of potential user, it appears necessary to
continue highlighting and seeking to understand
arguments of different kinds, this with a view to
pursuing interdisciplinary dialogue on matters of
technology development.
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